Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: insights downside risk payment models providers should consider
… Journal of Internal Medicine Symposium: Innovative Payment Models in Alzheimer’s Disease Share on: Friday, November 11, … Journal of Internal Medicine (JIM) Symposium: Innovative Payment Models in Alzheimer’s Disease. Determining the value …
… Benefit-Risk Preferences Benefit-risk preference studies are a specific application of … to gain the benefit of treatment—risks that others might consider unacceptable. Discrete-choice experiments (DCEs) …
… strategies and value messages, MCDA can be used to gain insights at each stage of your product’s lifecycle. We can … information that can help you understand and communicate risk tolerance from patients and other stakeholders to inform … clinical trial data, outcomes data, and published economic models, we can objectively score product attributes—allowing …
… feasibility assessment be conducted. This evaluation should consider the research question, data sources, study … to recommend stopping studies unlikely to provide valuable insights, protecting participants and preventing unnecessary … stop the study. Related Services Pharmacoepidemiology and Risk Management Staff Members John D. Seeger …
… Decision-Analytic Models for Health Economics Decision-analytic models provide a framework for compiling clinical and … you receive the most intuitive and technically sound models possible. Our multinational team has built hundreds of …
… Benefit-Risk Assessment Do your product’s benefits outweigh its … help you navigate the ever-evolving landscape of benefit-risk assessment and meet the requirements of regulatory and … measuring key benefits and risks that will resonate with providers and patients post-approval Identifying the best …
Delphi Panel Services Image Having high-quality data to inform decision-making is critical to your product’s development and success. But sometimes, unanticipated questions arise, and you need information quickly. What do you do if the data you need is …
… Pharmacoepidemiology and Risk Management Regulatory Real-World Evidence Research Let … activities. To understand disease distribution, risk factors, treatment patterns and impact, comorbidities, … other related factors, and the effectiveness of risk minimization interventions, or to evaluate safety and …
… strategy, for the best positioning of your product, you should begin in Phase 2 of clinical development. Tasks to support the strategy should include the following activities. …
… Health Economics Consulting: Strategy and Early Models A promising asset in development is just that—an … is often an early cost-effectiveness model (CEM). These models provide an objective evidence-based framework to …